Jury Selection Begins In High-Stakes Battle Over Stent Patents
Jury selection begins Monday in the closely watched patent dispute between Johnson & Johnson and Boston Scientific Corp. over the lucrative $5 billion market for drug-coated heart stents....To view the full article, register now.
Already a subscriber? Click here to view full article